Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

Detalles Bibliográficos
Autores principales: Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933678/
https://www.ncbi.nlm.nih.gov/pubmed/31881817
http://dx.doi.org/10.1186/s10194-019-1069-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933678/
https://www.ncbi.nlm.nih.gov/pubmed/31881817
http://dx.doi.org/10.1186/s10194-019-1069-x

Ejemplares similares